FDA Hold On Cloretazine Phase III Trial Is Lifted, Putting Vion On Track For 2008 NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Company concedes it could run out of cash in 2009 if cancer drug is not commercialized.